MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Immunomedics Company Profile (NASDAQ:IMMU)

Consensus Ratings for Immunomedics (NASDAQ:IMMU) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $5.00 (115.52% upside)

Analysts' Ratings History for Immunomedics (NASDAQ:IMMU)
Show:
DateFirmActionRatingPrice TargetActions
6/21/2016Wells FargoDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Jefferies GroupReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015OppenheimerReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2014Panmure GordonReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2014R. F. LaffertyDowngradeBuy -> Neutral$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Immunomedics (NASDAQ:IMMU)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/4/2016        
5/4/2016Q3($0.13)($0.15)$2.13 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2016Q216($0.14)($0.15)$1.23 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q116($0.14)($0.16)$1.23 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/19/2015Q415($0.13)($0.13)$1.13 million$2.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015($0.13)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015Q215($0.13)($0.12)$1.38 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014($0.12)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/25/2014Q414($0.12)($0.13)$1.20 million$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014($0.11)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2014Q214($0.10)($0.10)$1.20 million$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/22/2013Q4 2013($0.12)($0.09)$0.81 million$1.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q3 2013($0.10)$0.11$0.97 million$1.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Immunomedics (NASDAQ:IMMU)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)
Dividend History for Immunomedics (NASDAQ:IMMU)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Immunomedics (NASDAQ:IMMU)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/13/2016Cynthia L GoldenbergCEOSell371,990$3.03$1,127,129.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2016Cynthia L GoldenbergCEOSell41,441$3.62$150,016.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2016David M GoldenbergChairmanSell353,010$3.88$1,369,678.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Cynthia L GoldenbergCEOSell4,600$4.01$18,446.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016David M GoldenbergChairmanSell12,300$3.98$48,954.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Cynthia L GoldenbergCEOSell63,959$4.09$261,592.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016David M GoldenbergChairmanSell110,322$4.09$451,216.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015David M GoldenbergChairmanSell210,991$4.08$860,843.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Brian A MarkisonDirectorSell5,564$4.22$23,480.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015David M GoldenbergChairmanSell359,653$4.32$1,553,700.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Mary E PaetzoldDirectorSell4,677$4.60$21,514.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2015Don C StarkDirectorSell5,732$4.14$23,730.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014Mary E PaetzoldDirectorSell10,000$4.71$47,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Don C StarkDirectorSell5,500$4.51$24,805.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Don StarkDirectorSell10,000$6.08$60,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Immunomedics (NASDAQ:IMMU)
DateHeadline
06/29/16 10:51 AMSHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm - [Business Wire] - Khang & Khang LLP announces that a class action lawsuit has been filed against Immunomedics Inc. . Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive , are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
06/29/16 07:27 AMWhat Will Happen to Immunomedics, Inc. Next? The Stock Just Increased A Lot - Press Telegraph
06/28/16 09:00 PMSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Immunomedics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit – IMMU - [GlobeNewswire] - STEVENSON, Md., June 28, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ...
06/28/16 04:34 PMCheck on Share Volatility: Immunomedics Inc. (NASDAQ:IMMU) - Engelwood Daily
06/28/16 08:11 AMIMMUNOMEDICS ANNOUNCES NEW U.S. PATENT FOR SACITUZUMAB GOVITECAN (IMMU-132) ANTIBODY-DRUG CONJUGATE (ADC) - [at noodls] - Microsoft Word - IMMUNOMEDICS ANNOUNCES NEW US PATENT FOR IMMU-132 IMMUNOMEDICS,® INC. ... This is an abstract of the original noodl. To continue reading this document, click here for the original version....
06/27/16 04:36 PM3D Systems Corporation (NYSE:DDD) & Immunomedics, Inc. (NASDAQ:IMMU) Stocks are Roundup - Wall Street 24
06/27/16 04:36 PMEarnings Estimates Review: Immunomedics Inc. (NASDAQ:IMMU) - News Oracle
06/27/16 04:36 PMAnalysts Review of Stocks: Immunomedics, Inc. (NASDAQ:IMMU) , Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Street Updates
06/27/16 04:36 PMHC Stocks Buzzer: Antares Pharma Inc (NASDAQ:ATRS), Immunomedics, Inc. (NASDAQ:IMMU) - share market updates (press release)
06/27/16 04:30 PMDEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm - [Accesswire] - LOS ANGELES, CA / ACCESSWIRE / June 27, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company") (Nasdaq: IMMU) ...
06/27/16 03:50 PMIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm - [Business Wire] - Khang & Khang LLP announces that a class action lawsuit has been filed against Immunomedics Inc. . Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive , are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
06/27/16 09:21 AMINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Immunomedics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 - IMMU - [Accesswire] - NEW YORK, NY / ACCESSWIRE / June 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Immunomedics, ...
06/27/16 09:19 AMSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline: August 8, 2016 - [Accesswire] - NEW YORK, NY / ACCESSWIRE / June 27, 2016 / Bronstein, Gewirtz & Grossman, LLC, notifies investors of a class action against Immunomedics, Inc. ("Immunomedics" or the "Company") (NASDAQ-GM: ...
06/25/16 08:28 AMKhang & Khang LLP (the “Firm”) announces that a class action lawsuit has been filed against Chiasma, Inc
06/24/16 04:40 PMPomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline – IMMU
06/24/16 03:05 PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline – IMMU - [GlobeNewswire] - NEW YORK, June 24, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Immunomedics, Inc. and certain of its officers. The class action, filed in United States District Court, ...
06/24/16 07:14 AMSHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Class ... - Business Wire (press release)
06/24/16 07:14 AMAnalysts Update on Stocks: AbbVie Inc. (NYSE:ABBV) , Immunomedics, Inc. (NASDAQ:IMMU) - Street Updates
06/23/16 06:52 PMIMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm - [Business Wire] - Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016.
06/23/16 02:34 PMSHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Class Action - IMMU - [Business Wire] - Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities from April 20, 2016 through June 2, 2016, both dates inclusive of the important August 8, 2016 lead plaintiff deadline in the class action.
06/23/16 07:31 AMWells Fargo recorded (NASDAQ:IMMU) Immunomedics, upholding its price target to $0 today
06/23/16 07:31 AMImmunomedics announces it has a new CFO
06/23/16 04:30 AMDEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm - [Business Wire] - Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016.
06/22/16 04:43 PMForm 8-K IMMUNOMEDICS INC For: Jun 21 - StreetInsider.com
06/21/16 04:19 PMBRIEF-Immunomedics says appoints Garone as new CFO
06/21/16 04:19 PMForm 8-K IMMUNOMEDICS INC For: Jun 21
06/21/16 04:19 PMImmunomedics Shares Plunge After Finance Chief Steps Down
06/21/16 09:10 AMHC Stocks Assessment: Geron Corporation (NASDAQ:GERN), Immunomedics, Inc. (NASDAQ:IMMU) - share market updates (press release)
06/21/16 09:10 AMStocks Gainers/Losers Roundup- Immunomedics Inc. (NASDAQ:IMMU), Verizon Communications Inc. (NYSE:VZ ... - Seneca Globe
06/21/16 09:10 AMIMMUNOMEDICS, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of ... - Business Wire (press release)
06/21/16 08:45 AMIMMUNOMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
06/21/16 07:01 AM8:01 am Immunomedics replaces Peter Pfreundschuh with Michael Garone as CFO effective immediately -
06/21/16 07:00 AMImmunomedics Appoints Michael R. Garone as New Chief Financial Officer - [GlobeNewswire] - MORRIS PLAINS, N.J., June 21, 2016-- Immunomedics, Inc., today announced the appointment of Michael R. Garone as Vice President, Finance, and Chief Financial Officer. Garone replaces Peter P. Pfreundschuh, ...
06/20/16 04:52 PMIMMUNOMEDICS, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit - [Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc.
06/20/16 11:12 AMINVESTOR NOTICE: Lundin Law PC Announces Investigation Of Immunomedics Inc. And Advises Investors With Losses to Contact the Firm - [Business Wire] - Lundin Law PC announces it is investigating claims against Immunomedics Inc. concerning possible violations of federal securities laws.
06/20/16 10:04 AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 -- IMMU - [Marketwired] - The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Immunomedics, Inc. between April 20, 2016 and June 2, 2016. ...
06/20/16 03:00 AMHagens Berman Alerts Immunomedics, Inc. (NASDAQ: IMMU) Investors of Securities Class Action and August 8, 2016 Lead Plaintiff Deadline - [GlobeNewswire] - SAN FRANCISCO, June 20, 2016-- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts Immunomedics, Inc. investors of the August 8, 2016 Lead Plaintiff deadline in the securities ...
06/19/16 04:11 PMThis Weeks Broker Views For Immunomedics, Inc. (IMMU) - Fiscal Standard
06/18/16 04:06 PMImmunomedics, Inc (NASDAQ:IMMU) Under Fire After Misrepresenting Data At The 2016 Annual ASCO Meeting - Journal Transcript
06/18/16 04:06 PMImmunomedics Inc. (IMMU) Drops 5.39% on June 16 - Equities.com
06/17/16 09:07 PMIMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics Inc. - [Business Wire] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 8, 2016 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics Inc.
06/16/16 05:30 PMIMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a class action lawsuit has been commenced on behalf of shareholders of Immunomedics, Inc. - IMMU - [GlobeNewswire] - NEW YORK, June 16, 2016-- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf ...
06/16/16 04:12 PMSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Immunomedics, Inc. -- IMMU - [GlobeNewswire] - WILMINGTON, Del., June 16, 2016-- Rigrodsky & Long, P.A.:. Do you, or did you, own shares of Immunomedics, Inc.? Did you purchase your shares between April 20, 2016 and June 2, 2016, inclusive?
06/16/16 08:53 AMInvestors Targeted Stocks: Envision Healthcare Holdings, Inc. (NYSE:EVHC) , Immunomedics, Inc. (NASDAQ:IMMU) - Street Updates
06/16/16 08:53 AMIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Investigation of Immunomedics Inc. and Advises ... - Business Wire (press release)
06/15/16 08:59 PMIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Investigation of Immunomedics Inc. and Advises Investors with Losses to Contact the Firm - [Business Wire] - Lundin Law PC announces it is investigating claims against Immunomedics Inc. concerning possible violations of federal securities laws.
06/15/16 04:40 PMStocks Earnings Analysis Report: Immunomedics Inc. (NASDAQ:IMMU), Skyworks Solutions Inc. (NASDAQ:SWKS) - Beacon Chronicle
06/15/16 09:17 AMAnalyst Recommendations: Realty Income Corporation (NYSE:O), Immunomedics Inc. (NASDAQ:IMMU) - Beacon Chronicle
06/14/16 04:30 PMInvestor in Shares of Immunomedics, Inc. (NASDAQ:IMMU) Filed Lawsuit in Effort to Recover Losses
06/14/16 01:12 PMSHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Immunomedics, Inc. and a Lead Plaintiff Deadline of August 8, 2016 - IMMU - [GlobeNewswire] - NEW YORK, June 14, 2016-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Immunomedics, ...
About Immunomedics

Immunomedics logoImmunomedics, Inc. is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. The Company's technologies allow it to create humanized antibodies in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins. Its product candidates include 90Y-clivatuzumab tetraxetan. Its radiolabeled antibody is in a Phase III registration trial in patients with advanced pancreatic cancer. Its portfolio of investigational products also includes antibody-drug conjugates (ADCs). Its ADCs consist of sacituzumab govitecan (IMMU-132) and labetuzumab govitecan (IMMU-130), which are in Phase II trials for a number of solid tumors and metastatic colorectal cancer (mCRC), respectively. It has other product candidates that target solid tumors and hematologic malignancies, as well as other diseases, in clinical and pre-clinical development-stages.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: IMMU
  • CUSIP: 45290710
Key Metrics:
  • Previous Close: $2.25
  • 50 Day Moving Average: $3.48
  • 200 Day Moving Average: $2.83
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $219.95M
  • Current Quarter EPS Consensus Estimate: $-0.57 EPS
Additional Links:
Immunomedics (NASDAQ:IMMU) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha